Dishman Carbogen Amcis
Dishman Carbogen Amcis Performance
Day Range
- Low 162.10
- High 169.15
52 Week Range
- Low 80.00
- High 179.20
- Open Price164.05
- Previous Close163.20
- Volume461601
Start SIP in Dishman Carbogen Amcis
Start SIPDishman Carbogen Amcis Investment Rating
-
Master Rating:
-
Dishman Carbogen Amcis has an operating revenue of Rs. 2,568.32 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of -2% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 15% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -3% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 25 which is a POOR score indicating inconsistency in earnings, a RS Rating of 63 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 60 | 70 | 113 | 78 | 107 | 104 | 83 |
Operating Expenses Qtr Cr | 63 | 75 | 107 | 82 | 105 | 101 | 82 |
Operating Profit Qtr Cr | -3 | -5 | 6 | -3 | 1 | 3 | 1 |
Depreciation Qtr Cr | 25 | 25 | 23 | 3 | 35 | 35 | 34 |
Interest Qtr Cr | 17 | 18 | 17 | 15 | 14 | 13 | 10 |
Tax Qtr Cr | -3 | -12 | -9 | -4 | -10 | -15 | -38 |
Net Profit Qtr Cr | -6 | -21 | -10 | -7 | -17 | -25 | 5 |
Dishman Carbogen Amcis Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 10
- Bearish Moving Average
- ___
- 6
- 20 Day
- ₹163.32
- 50 Day
- ₹159.33
- 100 Day
- ₹153.96
- 200 Day
- ₹144.91
- 20 Day
- ₹162.96
- 50 Day
- ₹158.91
- 100 Day
- ₹156.65
- 200 Day
- ₹141.66
Dishman Carbogen Amcis Resistance and Support
Resistance | |
---|---|
First Resistance | 167.53 |
Second Resistance | 171.87 |
Third Resistance | 174.58 |
RSI | 51.91 |
MFI | 69.00 |
MACD Single Line | 3.47 |
MACD | 3.16 |
Support | |
---|---|
First Resistance | 160.48 |
Second Resistance | 157.77 |
Third Resistance | 153.43 |
Dishman Carbogen Amcis Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 492,245 | 17,248,265 | 35.04 |
Week | 368,458 | 15,265,225 | 41.43 |
1 Month | 822,385 | 32,204,613 | 39.16 |
6 Month | 968,401 | 34,571,918 | 35.7 |
Dishman Carbogen Amcis Result Highlights
Dishman Carbogen Amcis Synopsis
NSE-Medical-Diversified
Dishman Carbogen Amc is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 402.55 Cr. and Equity Capital is Rs. 31.36 Cr. for the Year ended 31/03/2023. Dishman Carbogen Amcis Ltd. is a Public Limited Listed company incorporated on 17/07/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L74900GJ2007PLC051338 and registration number is 051338.Market Cap | 2,559 |
Sales | 321 |
Shares in Float | 6.43 |
No of funds | 57 |
Yield |
Book Value | 0.62 |
U/D Vol ratio | 2 |
LTDebt / Equity | 4 |
Alpha | 0.19 |
Beta | 0.86 |
Dishman Carbogen Amcis
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 59.32% | 59.32% | 59.32% | 59.32% |
Mutual Funds | 3.28% | 2.9% | 2.32% | 3.63% |
Foreign Portfolio Investors | 8.8% | 8.9% | 9.34% | 7.2% |
Individual Investors | 24.64% | 24.57% | 24.62% | 25.65% |
Others | 3.96% | 4.31% | 4.4% | 4.2% |
Dishman Carbogen Amcis Management
Name | Designation |
---|---|
Mr. Janmejay R Vyas | Chairman |
Mr. Arpit J Vyas | Global Managing Director |
Mrs. Deohooti J Vyas | Whole Time Director |
Mr. Sanjay S Majmudar | Independent Director |
Mr. Ashok C Gandhi | Independent Director |
Mr. Rajendra S Shah | Independent Director |
Mr. Subir Kumar Das | Independent Director |
Mr. Maitri K Mehta | Director |
Dishman Carbogen Amcis Forecast
Price Estimates
Dishman Carbogen Amcis Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-11-08 | Quarterly Results | |
2023-08-09 | Quarterly Results | |
2023-05-23 | Audited Results | |
2023-02-10 | Quarterly Results | |
2023-01-17 | Others | Inter alia, to consider and approve the proposal of fund raising by way of issuance of Non-Convertible Debentures, by way of private placement. per share(10%)Final Dividend |
Dishman Carbogen Amcis FAQs
What is Share Price of Dishman Carbogen Amcis ?
Dishman Carbogen Amcis share price is ₹163 As on 04 December, 2023 | 01:42
What is the Market Cap of Dishman Carbogen Amcis ?
The Market Cap of Dishman Carbogen Amcis is ₹2558.7 Cr As on 04 December, 2023 | 01:42
What is the P/E ratio of Dishman Carbogen Amcis ?
The P/E ratio of Dishman Carbogen Amcis is -53.7 As on 04 December, 2023 | 01:42
What is the PB ratio of Dishman Carbogen Amcis ?
The PB ratio of Dishman Carbogen Amcis is 0.4 As on 04 December, 2023 | 01:42